1,734 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Hi-Tech Pharmaceuticals recalled 85,950 units of Beta Sitosterol on August 6, 2025 due to unapproved drug claims. The product supports cardiovascular health but lacks proper approval. Consumers should stop using the supplement immediately and contact the company for a refund.
SEASPINE Orthopedics recalled 74 units of the Reef TA Inserter on August 6, 2025. The device may cause difficulties in disengaging implants, leading to prolonged surgeries. Healthcare providers should stop using the device immediately and follow recall instructions.
Olympus Corporation of the Americas recalled 103,731 units of the ViziShot 2FLEX aspiration needle on August 6, 2025. The recall stems from a risk of undetected, deformed a-traumatic tips that could affect patient safety. The product is distributed worldwide, including the US, Australia, and Germany.
Getinge recalled 98 units of the VASOVIEW HEMOPRO 3 Endoscopic Vessel Harvesting System on August 5, 2025. The recall addresses out-of-box failures including malfunctioning jaws and heater wires. No serious injuries were reported related to these failures.
Hi-Tech Pharmaceuticals recalled 85,950 units of Quercetin dietary supplements on August 6, 2025. The recall stems from unapproved drug claims and misbranding. Consumers should stop using the product and seek refunds immediately.
Westminster Pharmaceuticals recalled 4,456 bottles of Metoprolol Tartrate Tablets on August 6, 2025. The recall follows the detection of a nitrosamine, N-nitroso-metoprolol, above acceptable daily intake levels. Consumers should immediately stop using this medication and consult healthcare providers.
Glenmark Pharmaceuticals recalled 17,496 bottles of Carvedilol Tablets on August 6, 2025. Tests revealed N-Nitroso Carvedilol Impurity-1 levels exceeded FDA limits. Consumers should stop using the medication immediately.
Westminster Pharmaceuticals recalled 16,672 bottles of Metoprolol Tartrate Tablets on August 6, 2025. The recall stems from high levels of a harmful nitrosamine, N-nitroso-metoprolol, exceeding the Acceptable Daily Intake. Consumers must stop using the tablets immediately and consult healthcare providers for guidance.
Haleon US Holdings recalled 46,692 tubes of Sensodyne PRONAMEL toothpaste on August 5, 2025, due to a labeling mix-up. The outer carton states Fresh Mint while the tube claims Cool Mint/Whitening. The actual product inside is Fresh Mint, leading to potential consumer confusion.
Philips Medical Systems recalled 810 units of its Radiation Therapy Planning System on August 5, 2025. A software issue may cause image errors during treatment planning. Affected models include Pinnacle TumorLOC and Multimodality Simulation Workspace.
Boston Scientific recalled 39,739 Encore 26 Inflation Devices on August 5, 2025. Foreign particles may migrate into balloon dilation catheters during use. Patients and healthcare providers must stop using the device immediately.
Boston Scientific recalled 1,369 UroMax Ultra Kits on August 5, 2025. Foreign particles may migrate from the Encore 26 Inflation Device into balloon dilation catheters. Patients and healthcare providers must stop using the device immediately.
Boston Scientific recalled 458 NephroMax Kits on August 5, 2025, due to contamination risk. The Encore 26 Inflation Device may allow foreign particles to enter balloon dilatation catheters. Patients must stop using the device immediately and follow recall instructions.
Sandoz Inc. recalled 10 bags of Enoxaparin Sodium Injection on August 5, 2025. Bags labeled for Enoxaparin Sodium 80 mg/0.8 mL contained the incorrect dosage of 30 mg/0.3 mL. Consumers and healthcare providers must stop using the product immediately.
Tandem Diabetes Care recalled 122,958 insulin pumps on August 5, 2025. A software defect may cause unexpected insulin boluses, leading to hypoglycemia. Patients should stop using the devices immediately and follow the manufacturer's instructions.
AVID Medical recalled 228 units of the Halyard CPT BASIC IR Pack on August 4, 2025. The recall follows reports of open header bag seals that may compromise sterility. Healthcare providers and patients should stop using the device immediately.
B. Braun Medical Inc. recalled 74,088 containers of Lactated Ringer's Injection on August 4, 2025. The recall stems from a lack of assurance of sterility and potential fluid leakage. Consumers and healthcare providers should discontinue use immediately and seek guidance.
B. Braun Medical Inc. recalled 23,100 containers of 0.9% Sodium Chloride Injection on August 4, 2025. The recall stems from a lack of assurance of sterility and potential fluid leakage. This product is distributed nationwide in the United States.
Hospira, Inc. recalled 15,750 vials of Sodium Bicarbonate Injection on August 4, 2025. The recall stems from a lack of assurance of sterility. Consumers and healthcare providers must stop using the product immediately.
Hospira, Inc. recalled 49,620 vials of Epinephrine Injection on August 4, 2025. The recall follows concerns about the lack of assurance of sterility. Consumers should stop using the product immediately.
AVID Medical recalled 57 units of the Halyard ENT Pack on August 4, 2025. The recall stems from potential open header bag seals that may compromise sterility. Patients and healthcare providers must stop using this device immediately.
Wasatch Photonics recalled 192 Raman spectrometers on August 4, 2025. Two potential laser safety failure modes could pose serious risks. No incidents have been reported, but excessive force or vibration may trigger failures.
Beckman Coulter recalled 116 DxC 500i Clinical Analyzer modules on August 4, 2025, due to potential processing delays. The defect may impact the accuracy of test results when ordering certain tests simultaneously. Healthcare providers and patients must stop using the device immediately and follow recall instructions.
Waldemar Link GmbH & Co. KG recalled eight units of the LinkSymphoKnee Tibial Component on July 31, 2025. The recall stems from a manufacturing error involving uncoated security screws. Patients and healthcare providers should stop using the device immediately.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.